| Myocardial rescue with autologous mitochondrial transplantation in a porcine model of ischemia/reperfusion AK Kaza, I Wamala, I Friehs, JD Kuebler, RH Rathod, I Berra, M Ericsson, ... The Journal of thoracic and cardiovascular surgery 153 (4), 934-943, 2017 | 197 | 2017 |
| Intracoronary delivery of mitochondria to the ischemic heart for cardioprotection DB Cowan, R Yao, V Akurathi, ER Snay, JK Thedsanamoorthy, ... PloS one 11 (8), e0160889, 2016 | 186 | 2016 |
| Transit and integration of extracellular mitochondria in human heart cells DB Cowan, R Yao, JK Thedsanamoorthy, D Zurakowski, PJ Del Nido, ... Scientific reports 7 (1), 17450, 2017 | 122 | 2017 |
| Potential antiviral options against SARS-CoV-2 infection A Ianevski, R Yao, MH Fenstad, S Biza, E Zusinaite, T Reisberg, ... Viruses 12 (6), 642, 2020 | 120 | 2020 |
| Mitochondrial transplantation enhances murine lung viability and recovery after ischemia-reperfusion injury K Moskowitzova, A Orfany, K Liu, G Ramirez-Barbieri, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 318 (1 …, 2020 | 94 | 2020 |
| Mitochondrial transplantation prolongs cold ischemia time in murine heart transplantation K Moskowitzova, B Shin, K Liu, G Ramirez-Barbieri, A Guariento, D Blitzer, ... The Journal of Heart and Lung Transplantation 38 (1), 92-99, 2019 | 84 | 2019 |
| Identification and tracking of antiviral drug combinations A Ianevski, R Yao, S Biza, E Zusinaite, A Männik, G Kivi, A Planken, ... Viruses 12 (10), 1178, 2020 | 64 | 2020 |
| Synergistic interferon-alpha-based combinations for treatment of SARS-CoV-2 and other viral infections A Ianevski, R Yao, E Zusinaite, LS Lello, S Wang, E Jo, J Yang, E Ravlo, ... Viruses 13 (12), 2489, 2021 | 29 | 2021 |
| Genetic interaction between the non‐homologous end‐joining factors during B and T lymphocyte development: In vivo mouse models S Castañeda‐Zegarra, M Fernandez‐Berrocal, M Tkachov, R Yao, ... Scandinavian Journal of Immunology 92 (4), e12936, 2020 | 25 | 2020 |
| Immunoregulatory intestinal microbiota and COVID-19 in patients with type two diabetes: a double-edged sword P Petakh, I Kamyshna, A Nykyforuk, R Yao, JF Imbery, V Oksenych, ... Viruses 14 (3), 477, 2022 | 24 | 2022 |
| Nafamostat–interferon-α combination suppresses SARS-CoV-2 infection in vitro and in vivo by cooperatively targeting host TMPRSS2 A Ianevski, R Yao, H Lysvand, G Grødeland, N Legrand, V Oksenych, ... Viruses 13 (9), 1768, 2021 | 23 | 2021 |
| Relaxin family member insulin‐like peptide 6 ameliorates cardiac fibrosis and prevents cardiac remodeling in murine heart failure models S Maruyama, CL Wu, S Yoshida, D Zhang, PH Li, F Wu, J Parker Duffen, ... Journal of the American Heart Association 7 (12), e008441, 2018 | 22 | 2018 |
| Mono-and combinational drug therapies for global viral pandemic preparedness A Ianevski, R Yao, RM Simonsen, V Myhre, E Ravlo, GD Kaynova, ... Iscience 25 (4), 2022 | 19 | 2022 |
| Leaky severe combined immunodeficiency in mice lacking non-homologous end joining factors XLF and MRI S Castañeda-Zegarra, Q Zhang, A Alirezaylavasani, ... Aging (Albany NY) 12 (23), 23578, 2020 | 16 | 2020 |
| Transit and fusion of exogenous mitochondria in human heart cells DB Cowan, R Yao, JK Thedsanamoorthy, D Zurakowski, PJ del Nido, ... Nature Sci Rep 7, 17450, 2017 | 8 | 2017 |
| Active Components of Commonly Prescribed Medicines Affect Influenza A Virus–Host Cell Interaction: A Pilot Study A Ianevski, R Yao, E Zusinaite, H Lysvand, V Oksenych, T Tenson, ... Viruses 13 (8), 1537, 2021 | 7 | 2021 |
| Potential antiviral options against SARS-CoV-2 infection. Viruses 12: 642 A Ianevski, R Yao, MH Fenstad, S Biza, E Zusinaite, T Reisberg, ... | 7 | 2020 |
| Interferon alpha-based combinations suppress SARS-CoV-2 infection in vitro and in vivo A Ianevski, R Yao, E Zusinaite, LS Lello, S Wang, E Jo, J Yang, E Ravlo, ... bioRxiv, 2021.01. 05.425331, 2021 | 6* | 2021 |
| COVID-19 in Patients with Type Two Diabetes: A Double-Edged Sword., 2022, 14, 477 P Petakh, I Kamyshna, A Nykyforuk, R Yao, JF Imbery, V Oksenych, ... DOI: https://doi. org/10.3390/v14030477, 0 | 5 | |
| Nafamostat-interferon-alpha combination suppresses SARS-CoV-2 infection by targeting cooperatively host TMPRSS2 in vitro and in vivo A Ianevski, R Yao, H Lysvand, G Grødeland, N Legrand, V Oksenych, ... bioRxiv, 2021.06. 16.448653, 2021 | 4 | 2021 |
